Hosted on MSN
ACADIA Pharmaceuticals Advances Phase 3 Study for Lewy Body Dementia Psychosis Treatment
ACADIA Pharmaceuticals Inc. ((ACAD)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert ...
Lewy Body Dementia (LBD) is a brain disease that’s often misunderstood. It’s actually the second most common type of progressive dementia after Alzheimer’s disease (AD). For patients and families, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback